Literature DB >> 33437681

Impact of COVID-19 on TB active case finding in Nigeria.

B Odume1, V Falokun1, O Chukwuogo1, C Ogbudebe1, S Useni1, N Nwokoye1, E Aniwada2, B Olusola Faleye3, I Okekearu3, D Nongo4, T Odusote4, A Lawanson5.   

Abstract

BACKGROUND: Active TB case finding (ACF) is a key strategy employed by the National Tuberculosis and Leprosy Control Programme (NTBLCP) to address the increasing gap in TB case finding in Nigeria. KNCV TB foundation Nigeria rolled out two high-impact ACF interventions; TB Surge and the Wellness on Wheels (WoW) campaigns from January 2020.
METHOD: The TB Surge intervention supports the engagement of ad hoc staff for TB ACF. The WoW campaign employs a mobile diagnostic unit to deliver care to the doorstep of people at risk of TB. Data along the TB cascade are recorded for all clients using the CommCare app. Cochran-Armitage χ2 test for linear trend was used to assess the significance declining trends along the TB cascade.
RESULTS: There was a progressive decrease of respectively 63%, 64%, 73% and 72% in clinic attendance, presumptive TB identification, TB cases detected and treatment initiation for the TB Surge ACF intervention since the emergence of coronavirus; a similar decrease was noted for the WoW intervention. Trend analysis showed a significant decline in trends for both interventions for all variables (P < 0.001).
CONCLUSION: The COVID-19 epidemic has impacted negatively on TB services in Nigeria. The TB programme could leverage some resources used to combat the epidemic such as digital health technology and funds, and work towards strengthening patient-centred approach to care to limit the challenges that COVID-19 presents to TB control.
© 2020 The Union.

Entities:  

Keywords:  TB cascade; TB surge; Wellness on Wheels; ad hoc staff

Year:  2020        PMID: 33437681      PMCID: PMC7790486          DOI: 10.5588/pha.20.0037

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  7 in total

1.  An evaluation of innovative community-based approaches and systematic tuberculosis screening to improve tuberculosis case detection in Ebonyi State, Nigeria.

Authors:  Daniel C Oshi; Joachim C Omeje; Sarah N Oshi; Isaac N Alobu; Ngozi E Chukwu; Chukwuemeka Nwokocha; Obiageli F Emelumadu; Chidubem L Ogbudebe; Anthony O Meka; Kingsley N Ukwaja
Journal:  Int J Mycobacteriol       Date:  2017 Jul-Sep

Review 2.  Post tuberculosis treatment infectious complications.

Authors:  Desmond Hsu; Muhammad Irfan; Kauser Jabeen; Nousheen Iqbal; Rumina Hasan; Giovanni Battista Migliori; Alimuddin Zumla; Dina Visca; Rosella Centis; Simon Tiberi
Journal:  Int J Infect Dis       Date:  2020-02-27       Impact factor: 3.623

Review 3.  Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes.

Authors:  Toyin Togun; Beate Kampmann; Neil Graham Stoker; Marc Lipman
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-05-23       Impact factor: 3.944

4.  Editorial: The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security.

Authors:  Alimuddin Zumla; Michael S Niederman
Journal:  Curr Opin Pulm Med       Date:  2020-05       Impact factor: 3.155

5.  Leveraging polymerase chain reaction technique (GeneXpert) to upscaling testing capacity for SARS-CoV-2 (COVID-19) in Nigeria: a game changer.

Authors:  Olanrewaju Oladimeji; Bamidele Paul Atiba; Daniel Adedayo Adeyinka
Journal:  Pan Afr Med J       Date:  2020-04-21

6.  The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis.

Authors:  Lucia Cilloni; Han Fu; Juan F Vesga; David Dowdy; Carel Pretorius; Sevim Ahmedov; Sreenivas A Nair; Andrei Mosneaga; Enos Masini; Suvanand Sahu; Nimalan Arinaminpathy
Journal:  EClinicalMedicine       Date:  2020-10-24

Review 7.  The potential impact of COVID-19-related disruption on tuberculosis burden.

Authors:  C Finn McQuaid; Nicky McCreesh; Jonathan M Read; Tom Sumner; Rein M G J Houben; Richard G White; Rebecca C Harris
Journal:  Eur Respir J       Date:  2020-08-13       Impact factor: 16.671

  7 in total
  9 in total

Review 1.  The impact of COVID-19 on communicable and non-communicable diseases in Africa: a narrative review.

Authors:  Beatrice Formenti; Natalia Gregori; Verena Crosato; Valentina Marchese; Lina Rachele Tomasoni; Francesco Castelli
Journal:  Infez Med       Date:  2022-03-01

2.  Emerging threat of drug-resistant tuberculosis and trends in the era of COVID-19: A descriptive study from northwestern Nigeria.

Authors:  Farouq Muhammad Dayyab; Garba Iliyasu; Bashir Garba Ahmad; Ibrahim Aliyu Umar; Nura Musa Shuaib; Mamman Bajehson; Ibrahim Muhammad Daiyab; Oji Akpala; Olaoye Remilekun; Abdulrazaq Garba Habib
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-05-17

3.  Missed Tuberculosis Investigations and Associated Factors in Patients with Symptoms Indicative of Tuberculosis at Public Health Institutions in Northwest Ethiopia: The Application of a Negative Binomial Model.

Authors:  Mulusew Andualem Asemahagn
Journal:  Infect Drug Resist       Date:  2022-04-19       Impact factor: 4.177

4.  The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response.

Authors:  Gizachew A Tessema; Yohannes Kinfu; Berihun Assefa Dachew; Azeb Gebresilassie Tesema; Yibeltal Assefa; Kefyalew Addis Alene; Atsede Fantahun Aregay; Mohammed Biset Ayalew; Woldesellassie M Bezabhe; Ayele Geleto Bali; Abel Fekadu Dadi; Bereket Duko; Daniel Erku; Kahsu Gebrekidan; Kidane Tadesse Gebremariam; Lemlem Gebremedhin Gebremichael; Eyob Alemayehu Gebreyohannes; Yalemzewod Assefa Gelaw; Hailay Abrha Gesesew; Getiye Dejenu Kibret; Cheru Tesema Leshargie; Maereg Wagnew Meazew; Alemayehu Mekonnen; Alemnesh H Mirkuzie; Hassen Mohammed; Dejen Yemane Tekle; Fisaha Haile Tesfay
Journal:  BMJ Glob Health       Date:  2021-12

5.  Tuberculosis in times of COVID-19.

Authors:  Alexandra Jaye Zimmer; Joel Shyam Klinton; Charity Oga-Omenka; Petra Heitkamp; Carol Nawina Nyirenda; Jennifer Furin; Madhukar Pai
Journal:  J Epidemiol Community Health       Date:  2021-09-17       Impact factor: 3.710

6.  Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020.

Authors:  Tasnim Hasan; Viet Nhung Nguyen; Hoa Binh Nguyen; Thu Anh Nguyen; Hien T T Le; Cuong D Pham; Nam Hoang; Phuong T M Nguyen; Justin Beardsley; Guy B Marks; Greg J Fox
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

Review 7.  PEPFAR's Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa.

Authors:  Carol W Holtzman; Catherine Godfrey; Lawal Ismail; Elliot Raizes; Julie A Ake; Fana Tefera; Salome Okutoyi; George K Siberry
Journal:  Curr HIV/AIDS Rep       Date:  2022-01-04       Impact factor: 5.495

Review 8.  Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic.

Authors:  Hung-Jen Tang; Chih-Cheng Lai; Chien-Ming Chao
Journal:  Antibiotics (Basel)       Date:  2022-02-25

Review 9.  The impact of COVID-19 on TB: a review of the data.

Authors:  C F McQuaid; A Vassall; T Cohen; K Fiekert; R G White
Journal:  Int J Tuberc Lung Dis       Date:  2021-06-01       Impact factor: 2.373

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.